• Clinical Trials
  • Publications
  • Careers
  • Contact Us
INOVIO Pharmaceuticals
  • About INOVIO
    • Purpose, Mission and Values
    • Leadership
    • Partnerships
  • DNA Medicines Technology
    • Optimized Plasmid Design and Delivery
    • DNA Medicines Explained
    • The Promise of DNA Medicine
    • NEXT GEN DNA MEDICINE
  • DNA Medicines Pipeline
  • Investors & Media
    • Events & Presentations
    • Stock Information
    • News Releases
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
    • Shareholder Services
    • FAQ
  • Clinical Trials
  • Publications
  • Careers
  • Contact Us
INOVIO Pharmaceuticals
NEWS ALERT

INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults

  • About INOVIO
  • DNA Medicines Technology
    • Optimized Plasmid Design and Delivery
    • DNA Medicines Explained
    • Technology Advantages
    • NEXT GENERATION DNA MEDICINE
  • DNA Medicines Pipeline
  • Investors & Media
    • Events & Presentations
    • Stock Information
    • News Releases
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
    • Shareholder Services
    • FAQ
  • Clinical Trials
  • Publications
  • Careers
  • Contact Us
  • Purpose, Mission and Values
  • Leadership
  • Partnerships

CEO CORNER

Dr. J. Joseph Kim

J. Joseph Kim, Ph.D.
President, Chief Executive Officer, Director

CEO CORNER

Dr. J. Joseph Kim

J. Joseph Kim, Ph.D.
President, Chief Executive Officer, Director
July 10, 2025

INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults

INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults

Read More

SUBSCRIBE FOR UPDATES FROM INOVIO
Register to receive email alerts for INOVIO press releases

INOVIO Pharmaceuticals
  • About Inovio
  • DNA Medicines Technology
  • DNA Medicines Pipeline
  • Investors & Media
  • For Patients
  • Publications
  • Careers
  • Contact Us
  • Safe Harbor Statement
  • Expanded Access
  • Privacy Policy
  • Terms & Conditions

© Copyright 2025 INOVIO Pharmaceuticals. All rights reserved.